跳至主要内容
临床试验/ISRCTN96337233
ISRCTN96337233已完成未知

A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's Disease

West Midlands NHS Research & Development Executive (UK)0 个研究点目标入组 310 人开始时间: 2002年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
310

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM IV) diagnosis of Alzheimer's disease, with or without evidence of vascular dementia
  • 2. Mild to moderate Alzheimer's disease (Mini Mental State Examination [MMSE] score 10 - 26)
  • 3. No definite contraindication to, or clear indication for, donepezil
  • 4. Not in residential care
  • 5. Regular carer
  • 6. Not have already taken donepezil or any other cholinergic enhancing agent

排除标准

  • Not provided at time of registration

研究者

发起方
West Midlands NHS Research & Development Executive (UK)

相似试验